249 related articles for article (PubMed ID: 32035930)
21. Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials.
Shan F; Miao R; Xue K; Li Z; Li Z; Bu Z; Wu A; Zhang L; Wu X; Zong X; Wang X; Li S; Ji X; Jia Z; Li Z; Ji J
Cancer Lett; 2016 Oct; 380(2):598-607. PubMed ID: 26724681
[TBL] [Abstract][Full Text] [Related]
22. A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib.
Roy S; Narang BK; Rastogi SK; Rawal RK
Anticancer Agents Med Chem; 2015; 15(1):37-47. PubMed ID: 25181996
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models.
Zopf D; Fichtner I; Bhargava A; Steinke W; Thierauch KH; Diefenbach K; Wilhelm S; Hafner FT; Gerisch M
Cancer Med; 2016 Nov; 5(11):3176-3185. PubMed ID: 27734608
[TBL] [Abstract][Full Text] [Related]
24. Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.
Xiang Q; Chen W; Ren M; Wang J; Zhang H; Deng DY; Zhang L; Shang C; Chen Y
Clin Cancer Res; 2014 Jun; 20(11):2959-70. PubMed ID: 24700742
[TBL] [Abstract][Full Text] [Related]
25. Angiogenic efficacy of simplified 2-herb formula (NF3) in zebrafish embryos in vivo and rat aortic ring in vitro.
Tse HY; Hui MN; Li L; Lee SM; Leung AY; Cheng SH
J Ethnopharmacol; 2012 Jan; 139(2):447-53. PubMed ID: 22138660
[TBL] [Abstract][Full Text] [Related]
26. Toxicity and anti-angiogenicity evaluation of Pak1 inhibitor IPA-3 using zebrafish embryo model.
Jagadeeshan S; Sagayaraj RV; Paneerselvan N; Ghouse SS; Malathi R
Cell Biol Toxicol; 2017 Feb; 33(1):41-56. PubMed ID: 27581547
[TBL] [Abstract][Full Text] [Related]
27. Anti-angiogenic Activity and Mechanism of Sesquiterpene Lactones from Centipeda minima.
Huang W; Yu X; Liang N; Ge W; Kwok HF; Lau CB; Li Y; Chung HY
Nat Prod Commun; 2016 Apr; 11(4):435-8. PubMed ID: 27396185
[TBL] [Abstract][Full Text] [Related]
28. In vivo Screening of Natural Products Against Angiogenesis and Mechanisms of Anti-Angiogenic Activity of Deoxysappanone B 7,4'-Dimethyl Ether.
Chen K; Fan Y; Gu J; Han Z; Zeng H; Mao C; Wang C
Drug Des Devel Ther; 2020; 14():3069-3078. PubMed ID: 32801645
[TBL] [Abstract][Full Text] [Related]
29. Pro-angiogenic activity of Tongnao decoction on HUVECs in vitro and zebrafish in vivo.
Wang J; Zhang XH; Xu X; Zhu Q; Yao B; Liang S; Chen Z; Wang Y; He MF; Wu M
J Ethnopharmacol; 2020 May; 254():112737. PubMed ID: 32147480
[TBL] [Abstract][Full Text] [Related]
30. Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.
Procaccio L; Damuzzo V; Di Sarra F; Russi A; Todino F; Dadduzio V; Bergamo F; Prete AA; Lonardi S; Prenen H; Palozzo AC; Loupakis F
Drug Saf; 2019 Feb; 42(2):159-179. PubMed ID: 30649744
[TBL] [Abstract][Full Text] [Related]
31. Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs.
Wanting H; Jian Z; Chaoxin X; Cheng Y; Chengjian Z; Lin Z; Dan C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5975-5987. PubMed ID: 36609710
[TBL] [Abstract][Full Text] [Related]
32. Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway.
Lin XL; Xu Q; Tang L; Sun L; Han T; Wang LW; Xiao XY
PLoS One; 2017; 12(5):e0177335. PubMed ID: 28489887
[TBL] [Abstract][Full Text] [Related]
33. Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.
Zhang WJ; Li Y; Wei MN; Chen Y; Qiu JG; Jiang QW; Yang Y; Zheng DW; Qin WM; Huang JR; Wang K; Zhang WJ; Wang YJ; Yang DH; Chen ZS; Shi Z
Cancer Lett; 2017 Feb; 386():100-109. PubMed ID: 27864115
[TBL] [Abstract][Full Text] [Related]
34. Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish.
Chen Y; Chen PD; Bao BH; Shan MQ; Zhang KC; Cheng FF; Cao YD; Zhang L; Ding AW
J Ethnopharmacol; 2018 Jun; 219():152-160. PubMed ID: 29126989
[TBL] [Abstract][Full Text] [Related]
35. Investigating the anti-angiogenic effects of Fufang Kushen Injection in combination with cisplatin using a zebrafish model.
Han L; Zhang W; Li X; He Q; Han J; Zhang Y; Sun C; Zhou H; Liu K
Pak J Pharm Sci; 2020 Sep; 33(5):1955-1960. PubMed ID: 33824101
[TBL] [Abstract][Full Text] [Related]
36. Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer.
Natsume M; Shimura T; Iwasaki H; Okuda Y; Kitagawa M; Okamoto Y; Hayashi K; Kataoka H
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1037-1046. PubMed ID: 30899983
[TBL] [Abstract][Full Text] [Related]
37. Anti-angiogenic and anticancer effects of baicalein derivatives based on transgenic zebrafish model.
Jiang X; Zhou J; Lin Q; Gong G; Sun H; Liu W; Guo Q; Feng F; Qu W
Bioorg Med Chem; 2018 Aug; 26(15):4481-4492. PubMed ID: 30098912
[TBL] [Abstract][Full Text] [Related]
38. Paeoniflorin Promotes Angiogenesis in A Vascular Insufficiency Model of Zebrafish in vivo and in Human Umbilical Vein Endothelial Cells in vitro.
Xin QQ; Yang BR; Zhou HF; Wang Y; Yi BW; Cong WH; Lee SM; Chen KJ
Chin J Integr Med; 2018 Jul; 24(7):494-501. PubMed ID: 27286711
[TBL] [Abstract][Full Text] [Related]
39. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologically induced angiogenesis in transgenic zebrafish.
Raghunath M; Sy Wong Y; Farooq M; Ge R
Biochem Biophys Res Commun; 2009 Jan; 378(4):766-71. PubMed ID: 19068208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
